Prediction of disease progression in early rheumatoid arthritis by ICTP, RF and CRP. A comparative 3-year follow-up study

Rheumatology

Volumn 39, Issue 9, 2000, Pages 1009-1013

  Aman S ^a   Paimela, L ^b   Leirisalo Repo, M ^c   Risteli, J ^a   Kautiainen, H ^d   Helve, T ^c   Hakala, M ^a  

^a UNIVERSITY OF OULU   (Finland)

^b Kuntoutus ORTON   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d RHEUMATISM FOUNDATION HOSPITAL   (Finland)

Author keywords

C reative protein; Collagen degradation; ICTP; Joint destruction; Prognosis; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 CARBOXYTERMINAL TELOPEPTIDE; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; PEPTIDE DERIVATIVE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS LINKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; GENDER; HAND RADIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK;

EID: 0033835927     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.9.1009     Document Type: Article

References (29)

1. Markers of bone and collagen breakdown in early inflammatory arthritis
2. Use of radiograph to measure the course of rheumatoid arthritis. The gold standard versus fool's gold
3. C-reactive protein in rheumatology
4. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis
5. Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis
6. Clinical, laboratory and radiographic features in early rheumatoid arthritis
7. Can we predict aggressive disease?
8. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
9. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma
10. Usefulness of bone metabolic markers in the diagnosis and follow-up of bone metastasis from lung cancer
11. Type I collagen degradation product in serum of patients with early rheumatoid arthritis. Relationship to disease activity and radiological progression in a 3-year follow-up
12. Increased type I collagen degradation in early rheumatoid arthritis
13. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis
14. Effect of the menopause and hormone replacement therapy on the carboxyterminal pyridinoline cross-linked telopeptide of type I collagen
15. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis
16. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
17. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
18. Improved immunoturbidimetry for rheumatoid factor testing
19. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films
20. Proposed modification to Larsen's scoring methods for hand and wrist radiographs
21. Comparison of the original and the modified Larsen methods and the Sharp method in scoring radiographic progression in early rheumatoid arthritis
22. Immunochemical characterization of assay for the carboxyterminal telopeptide of human type I collagen. Loss of antigenicity by treatment with cathepsin K
23. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial
24. The value of C-reactive protein measurement in rheumatoid arthritis
25. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
26. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis
27. A cross sectional analysis of 5 different markers of collagen degradation in rheumatoid arthritis
28. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
29. Application of markers of collagen metabolism in serum and synovial fluid for assessment of disease process in patients with rheumatoid arthritis